NCT00103311: SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer |
|
|
| Completed | 2 | 64 | US | ispinesib, laboratory biomarker analysis | National Cancer Institute (NCI) | Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer | 01/10 | 09/10 | | |
